The Value Investing Congress continued Tuesday in New York City, with stock investing ideas from Jeff Ubben, Jeff Smith and Mick McGuire.
*Adjusted EPS $0.95 vs est $0.89. *To target $300- $400 mln annually on acquisitions. Oct 26- Aon Plc's quarterly profit beat analysts' estimates as investments aimed at increasing margins at its human resources services unit helped boost profit, and the company said it planned a series of small acquisitions.
Here's a look at the Appleseed Fund, one of the strongest performers in the mid-cap value stock mutual fund category over the latest 5- year period, according to Morningstar. MANAGERS: Bill Pekin; Rick Singer; Adam Strauss; Joshua Strauss; Ronald Strauss. _ Sprott Physical Gold Trust.
Insurance broker Willis Group Holdings has named McKinsey& Co. senior partner Dominic Casserley its next CEO, starting Jan. 7. The London- based company also said Wednesday that Steve Hearn, 46, will serve as Willis Group deputy CEO.
Joseph Plumeri, chairman & CEO, Willis, tells CNBC why developing countries are the future of the insurance industry.
Not surprisingly, market technicians who were bullish two weeks ago are in a state of despair. Talk about minor support at 1,350 for the S&P 500 is half-hearted at best; the truth is that other than the March closing bottom of 1,273 there is no one willing to draw many lines in the sand here.
Willis Group Holdings, the world's third largest insurance brokerage, has agreed to buy rival Hilb Rogal & Hobbs for $1.7 billion, according to a statement late on Sunday.
Insurance broker Willis Group Holdings Ltd. has approached Marsh & McLennan about a possible takeover, CNBC has learned.
Shares in British reinsurance broker Benfield jumped almost 13% on Friday after a report it had received a 700 million pound ($1.4 billion) bid approach from the private equity arm of Goldman Sachs.
Marsh & McLennan said Friday that Brian Storms, CEO of the insurance broker's main operating subsidiary Marsh Inc., had been ousted. His departure, effective immediately, follows a 21 percent decline in Marsh & McLennan's stock price since May because of its financial underperformance.